For example, in a 2021 study, researchers examined the association of exosome-derived miRNAs to resistance to osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), in NSCLC. Here, EGFR is linked to non-small cell lung carcinoma.